An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.
Related Posts
Why America’s Berries Have Never Tasted So Good
Driscoll’s had to figure out how to breed, produce and sell its most flavorful strawberries and raspberries. Now the strategy is starting to bear fruit.
Southwest Raises Revenue Forecast, Plans Share Buyback in Activist Battle
The airline’s first flights with assigned seats are scheduled to take off in 2026, among a series of radical changes Southwest is making to its […]
Netflix Keeps Streaming Crown With Continued Subscriber, Revenue Growth
The streaming giant expects slower subscriber additions this quarter while lifting its revenue forecast for the year.